TaiGen Biopharmaceuticals Holdings Limited (4157.TWO)
TWD 8.97
(-7.33%)
TWD 8.97
(-7.33%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 34.15 Million TWD | 122.49% |
| 2022 | 15.35 Million TWD | -14.13% |
| 2021 | 17.87 Million TWD | 22.0% |
| 2020 | 14.65 Million TWD | 94.74% |
| 2019 | 7.52 Million TWD | 135.61% |
| 2018 | -21.12 Million TWD | 21.92% |
| 2017 | -27.05 Million TWD | 12.57% |
| 2016 | -30.94 Million TWD | 79.3% |
| 2015 | -149.49 Million TWD | -415.21% |
| 2014 | -29.01 Million TWD | -2901600100.0% |
| 2013 | 1.00 TWD | 0.0% |
| 2012 | - TWD | 0.0% |
| 2011 | - TWD | 0.0% |
| 2010 | - TWD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 49.02 Million TWD | -0.98% |
| 2024 Q1 | 49.5 Million TWD | 44.95% |
| 2023 Q3 | 32.35 Million TWD | 103.34% |
| 2023 Q4 | 34.15 Million TWD | 5.56% |
| 2023 FY | 34.15 Million TWD | 122.49% |
| 2023 Q1 | 15.77 Million TWD | 2.74% |
| 2023 Q2 | 15.91 Million TWD | 0.89% |
| 2022 Q1 | 17.61 Million TWD | -1.46% |
| 2022 FY | 15.35 Million TWD | -14.13% |
| 2022 Q4 | 15.35 Million TWD | -9.6% |
| 2022 Q2 | 16.88 Million TWD | -4.16% |
| 2022 Q3 | 16.98 Million TWD | 0.59% |
| 2021 Q3 | 18.62 Million TWD | -2.74% |
| 2021 Q4 | 17.87 Million TWD | -4.01% |
| 2021 Q1 | 19.67 Million TWD | 34.25% |
| 2021 Q2 | 19.14 Million TWD | -2.66% |
| 2021 FY | 17.87 Million TWD | 22.0% |
| 2020 Q2 | 18.2 Million TWD | -15.28% |
| 2020 Q1 | 21.48 Million TWD | 185.51% |
| 2020 Q3 | 15.09 Million TWD | -17.07% |
| 2020 FY | 14.65 Million TWD | 94.74% |
| 2020 Q4 | 14.65 Million TWD | -2.93% |
| 2019 Q1 | -21.15 Million TWD | -0.13% |
| 2019 Q4 | 7.52 Million TWD | 109.97% |
| 2019 FY | 7.52 Million TWD | 135.61% |
| 2019 Q3 | -75.47 Million TWD | 35.49% |
| 2019 Q2 | -116.99 Million TWD | -453.03% |
| 2018 Q4 | -21.12 Million TWD | -0.12% |
| 2018 FY | -21.12 Million TWD | 21.92% |
| 2018 Q3 | -21.1 Million TWD | 70.61% |
| 2018 Q2 | -71.79 Million TWD | -23.15% |
| 2018 Q1 | -58.29 Million TWD | -115.45% |
| 2017 FY | -27.05 Million TWD | 12.57% |
| 2017 Q2 | -30.99 Million TWD | -0.09% |
| 2017 Q3 | -31.03 Million TWD | -0.1% |
| 2017 Q4 | -27.05 Million TWD | 12.8% |
| 2017 Q1 | -30.97 Million TWD | -0.08% |
| 2016 FY | -30.94 Million TWD | 79.3% |
| 2016 Q4 | -30.94 Million TWD | 18.62% |
| 2016 Q3 | -38.02 Million TWD | -2.75% |
| 2016 Q2 | -37.01 Million TWD | -1020.53% |
| 2016 Q1 | -3.3 Million TWD | 97.79% |
| 2015 Q2 | -8.79 Million TWD | 92.29% |
| 2015 FY | -149.49 Million TWD | -415.21% |
| 2015 Q4 | -149.49 Million TWD | -239.7% |
| 2015 Q3 | -44 Million TWD | -400.42% |
| 2015 Q1 | -114.02 Million TWD | -292.99% |
| 2014 Q2 | 1.00 TWD | -100.0% |
| 2014 Q3 | -3 Million TWD | -300100000.0% |
| 2014 Q4 | -29.01 Million TWD | -866.88% |
| 2014 Q1 | 77.44 Million TWD | 7744199900.0% |
| 2014 FY | -29.01 Million TWD | -2901600100.0% |
| 2013 FY | 1.00 TWD | 0.0% |
| 2013 Q1 | - TWD | 0.0% |
| 2013 Q2 | 1.00 TWD | 0.0% |
| 2013 Q3 | -10.14 Million TWD | -1014900000.0% |
| 2013 Q4 | 1.00 TWD | 100.0% |
| 2012 Q4 | - TWD | 0.0% |
| 2012 FY | - TWD | 0.0% |
| 2011 FY | - TWD | 0.0% |
| 2010 FY | - TWD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 459.97 Million TWD | 92.575% |
| Level Biotechnology Inc. | 88.85 Million TWD | 61.56% |
| Sagittarius Life Science Corp | 31.54 Million TWD | -8.284% |
| NeoCore Technology Co., Ltd. | 66.38 Million TWD | 48.549% |
| TaiMed Biologics Inc. | 1.26 Billion TWD | 97.3% |
| GlycoNex Incorporation | 17.4 Million TWD | -96.254% |
| VBI | 10.03 Million TWD | -240.349% |
| GeneReach Biotechnology Corp. | 67.37 Million TWD | 49.307% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.17 Million TWD | -61.324% |
| Visgeneer Inc. | 49.07 Million TWD | 30.402% |
| Mycenax Biotech Inc. | 112.32 Million TWD | 69.594% |
| Sunmax Biotechnology Co., Ltd. | 93.67 Million TWD | 63.538% |
| G&E Herbal Biotechnology Co., Ltd. | 22.9 Million TWD | -49.118% |
| Medigen Vaccine Biologics Corporation | 383.63 Million TWD | 91.097% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -4.78 Million TWD | 813.176% |
| Enimmune corporation | 15.7 Million TWD | -117.528% |
| TaiRx, Inc. | 11 Thousand TWD | -310390.909% |
| CHO Pharma, Inc. | 1.00 TWD | -3415399900.0% |
| EirGenix Inc. | 680.63 Million TWD | 94.982% |
| BioLASCO Taiwan Co., Ltd. | 32.52 Million TWD | -5.012% |
| Sunny Pharmtech Inc. | 97.03 Million TWD | 64.804% |
| Lin BioScience, Inc. | - TWD | -Infinity% |
| BioGend Therapeutics Co., Ltd. | 16.54 Million TWD | -106.431% |
| Feng Chi Biotech Corp. | 19.03 Million TWD | -79.409% |
| Bio Preventive Medicine Corp. | 1.23 Million TWD | -2658.805% |
| Lukas Biomedical Inc. | 36.72 Million TWD | 7.001% |
| RBC Bioscience Corporation | 44.42 Million TWD | 23.116% |
| BiOptic Inc. | 161.07 Million TWD | 78.796% |
| BRIM Biotechnology, Inc. | -6.23 Million TWD | 647.515% |
| Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
| Great Novel Therapeutics Biotech & Medicals | 6.16 Million TWD | -454.358% |
| Syngen Biotech Co.,Ltd. | 348.98 Million TWD | 90.213% |
| Anti-Microbial Savior BioteQ Co., Ltd | 505 Thousand TWD | -6663.168% |
| SynCore Biotechnology Co.,Ltd | 3.12 Million TWD | -993.628% |
| Genomics BioSci & Tech. Co.,Ltd. | 61.5 Million TWD | 44.473% |
| Neith Corporation | 463 Thousand TWD | -7276.674% |
| Advagene Biopharma Co., Ltd. | -91.99 Thousand TWD | 37224.317% |
| NaviFUS Corp. | 6.87 Million TWD | -396.93% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 12.16 Million TWD | -180.687% |
| Sinew Pharma Inc. | -766 Thousand TWD | 4558.747% |
| Andros Pharmaceuticals Co.,Ltd | 1.08 Million TWD | -3039.154% |
| Greenyn Biotechnology Co., Ltd | 163.13 Million TWD | 79.064% |
| Lumosa Therapeutics Co., Ltd. | 103.91 Million TWD | 67.132% |
| AP Biosciences Inc | - TWD | -Infinity% |
| Medigen Biotechnology Corp. | 546.9 Million TWD | 93.755% |
| 3D Global Biotech Inc. | 3.59 Million TWD | -850.042% |
| Pharmosa Biopharm Inc. | 21.9 Million TWD | -55.89% |
| Intech Biopharm Corporation | 41.52 Million TWD | 17.751% |
| Oneness Biotech Co., Ltd. | 122.73 Million TWD | 72.173% |
| Eusol Biotech Co.,Ltd. | -8.1 Million TWD | 521.55% |
| TWi Biotechnology, Inc. | -435 Thousand TWD | 7951.494% |
| Ever Supreme Bio Technology Co., Ltd | 69.08 Million TWD | 50.563% |
| TCI GENE Inc. | 54.84 Million TWD | 37.729% |
| MegaPro Biomedical Co., Ltd | 20.51 Million TWD | -66.524% |
| Senhwa Biosciences, Inc. | - TWD | -Infinity% |
| Taiwan Bio Therapeutics Co., Ltd | 40.96 Million TWD | 16.624% |
| NatureWise Biotech & Medicals Corporation | 82.5 Million TWD | 58.601% |
| PharmaEngine, Inc. | 15.9 Million TWD | -114.792% |
| Savior Lifetec Corporation | 860.04 Million TWD | 96.029% |
| OBI Pharma, Inc. | 25.93 Million TWD | -31.706% |
| Meribank Biotech Co., Ltd | 6.9 Million TWD | -394.484% |
| Acepodia, Inc. | 39.52 Million TWD | 13.595% |
| Caliway Biopharmaceuticals Co., Ltd. | 1.02 Million TWD | -3238.612% |